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Abstract
Background: Gamma glutamylcyclotransferase (GGCT) has been proved to be involved in various cancers, but the
biological function of GGCT in gastric cancer is still largely unknown.
Methods: The expression level of GGCT was evaluated by informatics analyses based on the Oncomine database.
GGCT gene was then effectively knocked down via lentivirus mediated short hairpin RNA (shRNA) system. Then a
series of functional assays, including MTT, colony formation and flow cytometry analysis were conducted on gastric
cancer cells following GGCT knockdown.
Results: We found GGCT is commonly up-regulated in gastric cancer tissues. Furthermore, MTT analysis showed
that GGCT depletion significantly inhibited cell proliferation in MGC80-3 and AGS cells. Colony formation assay
revealed that depletion of GGCT reduced the colony formation ability in gastric cancer cells. What’s more, cell cycle
analysis showed that depletion of GGCT induced gastric cancer cell cycle arrested G2/M phase. More importantly,
cell apoptosis analysis further revealed that GGCT inhibition induced early and late cell apoptosis in gastric cancer.
Conclusion: This study suggests GGCT is essential for gastric cancer proliferation and its downregulation may
provide a potential anticancer therapy for gastric cancer.
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Background
Gastric cancer, as a common cancer, has the third highest
mortality rate in both sexes worldwide, especially in devel-
oping countries and regions [1]. However, lack of effective
early diagnostic methods makes gastric cancer usually be
diagnosed at late stages and missed the best treatment
time for curative surgery and radiotherapy [2, 3]. Mean-
while, chemotherapy usually causes severe side effects,
such as nausea, vomit, white blood cell reduction etc., and
thus is not suitable for elder or weak patients. Hence, early
diagnosis and targeted therapy are critical for better prog-
nosis of gastric cancer in the future. It has been reported
that multiple gene abnormalities led to the initiation and
development of gastric cancer [4]. Thus, investigating the
underling mechanisms and identifying key genes of gastric
cancer will provide novel evidences for early diagnosis and
targeted therapy against gastric cancer.
Gamma glutamyl cyclotransferase/glutamyl cyclotransfer-
ase-γ (GGCT), as a critical enzyme in the regulation of a γ-
glutamyl cycle via mediation of glutathione degradation, can
specifically convert γ-Glu-AA into pyroglutamate (pyroGlu)
[5]. It has been reported that GGCT was strongly accumu-
lated in various cancers, including breast, bladder, esopha-
gus, stomach and lung cancers [6–12]. Knockdown of
GGCT can suppress cell proliferation ability in bladder can-
cer cells [13] and induced the cell cytotoxicity against MCF-
7/ADR cells in vitro and in vivo [13]. Taken together, GGCT
was overexpressed in many cancer cells, including gastric
cancer. However, the underling mechanism of how GGCT
regulates gastric cancer remains elusive.
To explore the biological function and its underlying
mechanism of GGCT in human gastric cancer, the
present study firstly confirmed that the expression level
of GGCT is highly in gastric cancer tissues by analyzing
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data derived from Oncomine database. Knockdown of
GGCT with the shRNA system significantly suppressed
cell features, including cell proliferation, colony forma-
tion ability in gastric cancer cells. Furthermore, we
found that depletion of GGCT promotes late apoptosis
and induced gastric cancer cells to be arrested in sub-G1
and G2/M phases. These results indicated that GGCT
plays an important role in cell proliferation and progres-
sion of gastric cancer.
Methods
Cell lines and cell culture
Human gastric cancer cells (MGC80-3and AGS), and hu-
man embryonic kidney 293T (HEK293T) cell lines were
purchased from the Cell Bank of Chinese Academy of
Science (Shanghai, China). MGC80-3 and AGS cells were
maintained in RPMI 1640 medium (Hyclone, Cat no.
SH30809.01B) with 10% fetal bovine serum (FBS, Cat no.
04-001-1A-1351574). HEK293T cells were cultured in
DMEM medium (Hyclone, Cat no. SH30243.01B+) with
10% FBS. All of the cells were maintained at 37 °C in a hu-
midified atmosphere with 5% CO2.
Oncomine database analysis
The informatics data on GGCT mRNA expression in
stomach cancers were obtained from the Oncominedata-
base (https://www.oncomine.org). Wang et al. (GEO ac-
cession GSE19826) [14] and Cui et al. (GEO accession
GSE27342) [15] datasets were used to compared expres-
sion levels of GGCT between gastric cancer and normal
gastric tissues according to the standard procedures as
previously described [16].
Interference vector construction and infection
The shRNA oligos for GGCT gene knockdown were de-
signed and cloned into the lentiviral expression vector
(pFH-L, Shanghai Hollybio, China) between restriction




3′ was used as negative control. The two recombinant
vectors were designated Lenti-shGGCT and Lenti-shCon,
respectively. These plasmid DNAs were transfected into
the E.coli DH5α competent cells and then the cells were
purified with the endotox in-free plasmid purification kit
(Qaigen, CA, USA). PCR and sequencing analyses were
conducted to confirm the successful ligation. These
shRNA vectors and packaging pHelper plasmids (pVSVG-
I and pCMV△R8.92) (Shanghai Hollybio, China) were co-
transfected into HEK293T cells. At 96 h after transfection,
supernatant was collected and centrifuged to obtain the
lentiviruses. The titer of lentiviruses was determined
through counting Green Fluorescent Protein (GFP)-
positive cells under a fluorescence microscope (Olympus,
Tokyo, Japan). Titer was calculated as IU/ml = (the num-
bers of GFP-positive cells) × (dilution factor)/(volume of
virus solution). MGC80-3 and AGS cells were infected
with the viruses at the MOI of 60 and mock-infected cells
were used as negative control.
Quantitative RT-PCR (qRT-PCR) analysis
MGC80-3 and AGS cells were harvested at 5 days post
infection. Total RNA of the cells was extracted with
TRIzol® reagent (Invitrogen, Cat no.15596-018) separ-
ately. The purity and integrity of total RNA was assessed
by spectrophotometry and agarose gel electrophoreshs,
respectively. First-strand cDNA was then synthesized
with 1 μg RNA using the Reverse Transcription System
(BioRad, CA, USA). The sequences of qRT-PCR primers
were as follows: 5′-CAGCAACCTGCTGACAGAGA-3′
(forward) and 5′-CCCTTCTTGCTCATCCAGAG-3′
(reverse) for GGCT,5′-GTGGACATCCGCAAAGAC-3′
(forward) and 5′-AAAGGGTGTAACGCAACTA-3′ (re-
verse) for Actin. PCR reaction was carried out through
with BioRad Connet Real-Time PCR platform. And the
conditions were 1 min at 95 °C, 40 cycles of 95 °C for
5 s, and 60 °C for 20 s, read absorbance value at the ex-
tension stage.
Western blot
MGC80-3 and AGS cells were harvested at the 5th day
post infection. Then cells were lysed in 2× SDS Sample
Buffer (100 mM Tris-HCl, pH = 6.8, 10 mM EDTA, 4%
SDS, 10% Glycine). The concentration of protein in the
cell lysate was determined using the BCA protein assay
kit (Pierce Biotechnology, Cat no. 23235). Totally, 30 μg
of protein was loaded on per lane, followed by separ-
ation using SDS-PAGE, and transfer to PVDF mem-
brane. Then the membrane was subsequently incubated
with primary antibodies, including rabbit anti-human-
GGCT (Sigma, Cat no. HPA020735, 1:500), rabbit anti-
human-GAPDH (Proteintech Group, Inc., Cat no.
10494-1-AP, 1:60000), overnight at 4 °C, which was
followed by incubation with secondary antibody, horse-
radish peroxidase-conjugated anti-rabbit IgG (Santa
Cruz, Cat no.SC-2054, 1:5000), for 1 h at room
temperature. Blots were visualized using ECL Test Kit
(Amersiam, Cat no. RPN2132). GAPDH was used as the
internal control. Density analysis was carried out using
Quantity One software (BioRad).
Cell proliferation and colony formation assays
The cell viability of MGC80-3 and AGS cells before and
after infection was tested using the MTT assay. MGC80-
3 and AGS cells were plated at a density of 2000 cells/
well in a 96-well plate after 4 days of lentivirus infection.
For MTT assay, MTT solution was added into each well
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every day of the next 5 days and incubated at 37 °C in
humidified atmosphere with 5% CO2 for 4 h, and then
150 μl acidic isopropanol (0.01 M HCl, 10% SDS, 5% iso-
propanol) was added. Absorbance values at 595 nm were
measured with Epoch Microplate Spectrophotometer
(Biotek, CA, USA).
To judge colony formation abilities of the cells, trans-
fected MGC80-3 cells were seeded in a 6-well plate at
the concentration of 400 cells/well after 4 days of infec-
tion. Cells were fixed with methanol and, stained with
1% crystal violet (Beyotime Cat no. C0121) for 10 min,
then gently washed with water and dried in air. Visible
colonies containing more than 50 cells were manually
counted under fluorescence microscopy. Image analysis
was performed using Image-Pro®PlusVersion 6.0 (Media
Cybernetics, MD, USA).
Cell cycle analysis
Cell cycle distribution was analyzed using PI (propidium
iodide) following the manufacturer’s instructions. Briefly,
MGC80-3 cells were seeded in 6 cm dishes at 5 × 104
cells/dish 4 days after lentivirus infection. After 6 days of
cultivation, cells were washed and suspended in PBS con-
taining 50 μg/ml RNase A (Sigma-Aldrich) and 50 μg/ml
PI for 1 h in the dark. Fluorescence associated cellsorting
(FACS) assay with FACSCalibur (Beckman Coulter, CA,
USA) was used to count cell populations in each cell cycle
phases and the results were analyzed with the ModFit
(Verity Software House, Maine, USA) software.
Apoptosis assay
MGC80-3 cells (1 × 105/well) were collected after 48 h of
transfection with Lenti-shGGCT or Lenti-shCon and
stained with both Annexin V (allophycocyanin [APC] con-
jugated) and Propidium Iodide (PI) according to the man-
ufacturer’s instructions (BD Biosciences, Erembodegem,
Belgium). Apoptosis was detected by flow cytometry (BD
FACSCalibur).
Statistical analysis
The results were expressed as the mean ± SD. Statistics
were analyzed using SPSS software version 13.0. The
student’s t-test was used to evaluate the difference
between Lenti-shGGCT and Lenti-shCon group. The p-
value < 0.05 was considered as statistically significant.
Results
GGCT mRNA was overexpressed in gastric cancer
As GGCT has been reported to be upregulated in sev-
eral cancers, we conducted a review of previous micro-
array data for the expression of GGCT on mRNA level
in human gastric cancers. Results of searches in Onco-
mine database (Fig. 1) revealed that expression of GGCT
was significantly increased in human gastric cancer as
compared with healthy gastric tissues as shown in Wang
(p = 0.001) and Cui datasets (p = 0.008).
Lenti-shGGCT reduces GGCT expression in human gastric
cancer MGC80-3 and AGS cells
To explore the role GGCT plays in human gastric can-
cer, a lentiviral vector system expressing shRNA against
GGCT was constructed in MGC80-3 and AGS cells.
GFP was applied as a reporter gene. The high rate of
GFP-positive cells was observed by fluorescence micros-
copy at 96 h post-infection (Fig. 2a), which suggests the
high efficiency of infection. The GGCT knock-down effi-
ciency was further validated at both mRNA and protein
levels. As Fig. 2b and c display, the relative mRNA and
protein expression of GGCT (p < 0.001) were signifi-
cantly decreased in the MGC80-3and AGS cells infected
by Lenti-shGGCT, compared with the cells infected with
Lenti-shCon and the control cells. Those results indi-
cated that the Lenti-shRNA infection system exerted
Fig. 1 GGCT is up-regulated in Oncomine database analysis. Integrative analysis of GGCT mRNA expression levels in gastric cancer vs. normal gastric
type. A box plot shows relative mRNA expression level of GGCT in Wang and Cui datasets grouped by gastric cancer and normal tissue, respectively.
p value indicates the significant difference between two groups
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powerful and specific knock-down effects on GGCT ex-
pression in MGC80-3 and AGS cells.
Lenti-shGGCT suppressed the viability and proliferation of
MGC80-3 and AGS cells
To discover the potential functions of GGCT in gastric
cancer, the cell proliferation assay was conducted. The
Lenti-shCon and Lenti-shGGCT infected MGC80-3 and
AGS cells were seeded on 96-well plates for a MTT
assay in the following 5 days. Interestingly, the depletion
of GGCT significantly attenuated the proliferation ability
of MGC80-3 and AGS cells, as compared with that in
Lenti-shCon infected and control cells (Fig. 3a, p <
0.001). In addition, colony formation plays a critical role
in the development of tumor in vivo. To study whether
GGCT depletion affected the clonogenic potential of
gastric cancer cells, the colony formation assay was per-
formed in MGC80-3 cells. As Lenti-shGGCT infected
MGC80-3 cells exhibited a complete GGCT depletion, it
resulted in better performance in proliferation assay as
compared with that in AGS cells. Notably, much less
colonies formed in Lenti-shGGCT infected MGC80-3
cells, compared toMGC80-3 cells infected with Lenti-
shCon (p < 0.001) (Fig. 3b and c). These results indicated
that GGCT depletion significantly slowed cell prolifera-
tion and suppressed colony formation potential of
MGC80-3 cells.
GGCT depletion caused cell cycle arrest in MGC80-3 cells
To identify the mechanism underling the anti-
proliferation effect of GGCT depletion, cell cycle distribu-
tion of shGGCT-infected MGC80-3 cells was analyzed by
flow cytometry (Fig. 4a). There was a significant reduction
of cell number of Lenti-shGGCT infected MGC80-3 cells
in G0/G1 phase and a corresponding increase in G2/M
phase, compared with Lenti-shCon infected and control
Fig. 2 Lentivirus-mediated shRNA specifically reduced GGCT expression in MGC80-3 and AGS cells. a Green fluorescent images of MGC80-3 cells
under a 100× magnification microscope and under inverted fluorescent microscope at 96 h after lentivirus infection, showing the successful infection
of lentivirus expressing Lenti-shGGCT, Lenti-shCon, or Con, Scale bars, 10 μm. b The mRNA levels of GGCT in MGC80-3 and AGS cells after lentivirus
infection analyzed by qRT-PCR. c GGCT protein levels in MGC80-3 and AGS cells after lentivirus infection analyzed by Western blot. ***p < 0.001
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cells (Fig. 4b). In addition, infection of lenti-shGGCT re-
sulted in a remarkable increase of MGC80-3 cell number
in the sub-G1 phase (Fig. 4c) suggesting that GGCT de-
pletion might induce cell apoptosis.
GGCT depletion caused cell apoptosis
In order to determine the effects of GGCT depletion on
apoptosis of gastric cancer cell, Annexin V/PI double
staining was performed on MGC80-3 cells. Interestingly,
after observing Annexin V/PI double positive cells, it
was found that depletion of GGCT largely promoted late
apoptosis (Fig. 5a). Statistical analysis revealed that ap-
proximately 30-fold and 15-foldincrease of late apoptotic
populations was detected in Lenti-shGGCT-infected
MGC80-3 cells (31.4% ± 0.49%), as compared to Lenti-
shCon-infected and control MGC80-3 cells (1.14% ±
0.08%, 2.28% ± 0.10%), respectively (Fig. 5b, p < 0.001).
These results indicated downregulation of GGCT could
promote cell apoptosis in gastric cancer cells.
Discussion
Gastric cancer is one of the most common causes of
cancer-related death worldwide as usually be diagnosed
at late stages and missed the best treatment time [2, 3].
Thus, early diagnosis and targeted therapy are critical
for better prognosis of gastric cancer. To investigate the
underling mechanisms and identify key molecular
markers will provide novel evidences for early diagnosis
and targeted therapy against gastric cancer. GGCT is a
critical enzyme that regulates the biological processes of
glutathione, which is the major antioxidant in cells.
Herein, we identified GGCT was expressedhigher in hu-
man gastric cancer tissues than normal tissues. Knock-
down of GGCT weakened cell proliferation and colony
formation abilities of gastric cancer cells via increasing
cell cycle arrest and inducting late apoptosis. These find-
ings not only clarify the effects of GGCT depletion on
gaistric cancer, but also provide new evidence and basis
for new methodsof early diagnosisand target treatment
of gastric cancer.
Recently, GGCT has been found strongly accumulated
in various cancers, including breast, bladder, esophagus,
stomach and lung cancers [6–12]. Based on theanalysis of
two independent studies in Oncomine database, we found
that GGCT is highly accumulated in gastric cancer cells.
Furthermore, it has beenproved thatGGCTfunctioned as a
Fig. 3 Knockdown of GGCT inhibited the viability and proliferation of MGC80-3 and AGS cells. a The growth curve of MGC80-3 and AGS cells with
different treatments (Con, Lenti-shCon, or Lenti-shGGCT) assessed by MTT assay. b Images of MGC80-3 cells recorded under micro and macro view,
representing the size and the number of colonies in each group of cells. c Statistical analysis for the number of colonies formed in MGC80-3 cells with
different treatments (Con, Lenti-shCon, or Lenti-shGGCT). All data represented as mean ± SD from 3 independent experiments. ***p < 0.001
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novel biomarker of esophageal squamous malignancies, as
its expression levels strongly correlated with lymph node
metastasis and differentiation degree [6–11], in consistent
with that overexpression and depletion of GGCT resulted
in proliferative and antiproliferative activities in bladder
cancer cells, respectively [9]. Here, we observed that GGCT
depletion could remarkably inhibit cell proliferation and
colony formation activities ofhuman gastric cancer cells.
Furthermore, results of cell cycle and apoptosis ana-
lysis revealed that GGCT inhibition negatively regulated
gastric cancer progression via induction of cell arrest
and late apoptosis in MGC80-3 cells, in consistent with-
the study of GGCT in lung cancer [17]. In previous
studies, it wasindicatedthat knockdown of GGCT weak-
ened proliferation and colony formation abilities of lung
cancer cells through G0/G1 phase arrest. Moreover, the
Fig. 4 Knockdown of GGCT induced cell cycle arrest during G2/M and Sub-G1phase in MGC80-3 cells. a FACS analysis of cell cycle distribution in
MGC80-3 cells. A hypodiploid apex representing the apoptotic cells was found before the G1apex in Lenti-shGGCT infected MGC80-3 cells.
b Down-regulation of GGCT in MGC80-3cells led to an increase of cells at G2/M phase and concomitantly a decrease of cells at G0/G1
phase. c Down-regulation of GGCT in MGC80-3 cells led to an increase of cells at Sub-G1 phase. Data represents mean ± SD from 3 independent
experiments. ** p < 0.01, ***p < 0.001
Fig. 5 Knockdownof GGCT induced cell apoptosis in MGC80-3 cells. Apoptosis cells were assessed by Annexin V/PI double staining and then were
subjected to flow cytometry analysis. a Representative images showing Annexin V/PI staining results in MGC80-3 cells with different treatments (Con,
Lenti-shCon, or Lv-sh GGCT). b Statistical analysis of the apoptosis assay. **p < 0.01; ***p < 0.001. The experiment was performed in triplicates
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expression levels of G0/G1-associated markers, CDK4,
CDK6, and cyclin D1, declinedand the expression level
of cleaved PARP was obviously increased in GGCT
knockdown cells [17]. Ohno et al. found that GGCT is
closely associated with cell cycle [9], which was consist-
ent with our finding that depeletion of GGCT arrested
MGC80-3 gastric cancer cells in the sub-G1 and G2/M
phases, suggesting that knockdown of GGCT inhibited
cell phase transition and suppressed cell proliferation.
Whether GGCT suppress cell proliferation through
common cell cycle realted molecules, like cyclins and
cdks, will provide deeper understanding of the mechan-
ism and needs further investigation.
Furthermore, to alter gene expression in cells, there
were various methods, such as RNAi with shRNA or
siRNA. This study has generated efficient and stable
GGCT depletion cell lines using shRNA-based GGCT
knock-down technique instead of siRNA. AlthoughsiRNA
has been widely used as a therapeutic tool [18], adminis-
tration of siRNA often have problems of poor stability,
low transfection efficiency, and lowtissue penetration. The
shRNA-based GGCT depletion provides a more stable
and reliabe method for lab research use [19].
Conclusion
The present study statedthat GGCT was upregulated in hu-
man gastric cancer tissues. Knockdown of GGCT inhibits
cell proliferation and colony formation via increasing cell
cycle arrest and inducting late apoptosis. These findings
not only clarify the effects of GGCT depletion on gaistric
cancer, but also provide new evidence for development of
early diagnosis and targeted therapies of human gastric
cancer. However, what is the potential correlation between
the dysregulated cycle of glutathione and cell division, and
whether downregulation of GGCT interferes with the
transportation of amino acids leading to cell division dis-
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